Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice

Pancreatic ductal adenocarcinoma (PDAC) will soon belong to the top three cancer killers. The only approved specific PDAC therapy targets the epidermal growth factor receptor (EGFR). Although EGFR is a crucial player in PDAC development, EGFR‐based therapy is disappointing. In this study, we evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedegger, Kathrin, Algül, Hana, Lesina, Marina, Blutke, Andreas, Schmid, Roland M., Schneider, Marlon R., Dahlhoff, Maik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400790/
https://www.ncbi.nlm.nih.gov/pubmed/32335999
http://dx.doi.org/10.1002/1878-0261.12699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400790/
https://www.ncbi.nlm.nih.gov/pubmed/32335999
http://dx.doi.org/10.1002/1878-0261.12699

Ejemplares similares